MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Association between serum Vitamin D levels and Parkinson’s disease: A systematic review and meta-analysis

    XY. Luo, R. Ou, HF. Shang (Chengdu, China)

    Objective: The aim of this systematic review and meta-analysis was to evaluate the association between serum vitamin D levels and the risk and severity of…
  • 2018 International Congress

    Protective effects of Mucuna pruriens seed on rat brain: A therapeutic potential drug for Parkinson’s disease

    S. Rajput, S. Sinha (New Delhi, India)

    Objective: Objective of present study was evaluate neuroprotective and antiparkinson effects of Mp seed extract on Parkinsons brain of rats. Background: Parkinson’s disease (PD) is…
  • 2018 International Congress

    Assessment of clinical peculiarities of violations of vertical vision in patients with Parkinson’s disease

    M. Salokhiddinov, D. Akramova (Tashkent city, Uzbekistan)

    Objective: To study vertical oculomotor reflexes and the state of the functional system "eyelid" in patients with PD. Background: Parkinson's disease (PD) is a common…
  • 2018 International Congress

    Prefrontal cortical stimulation to treat anxiety and depression in Parkinson’s disease

    C. de Hemptinne, W. Chen, C. Racine, A. Seritan, A. Miller, J. Mergenthaler, S. Rajagopalan, J. Ostrem, M. San Luciano, P. Starr (San Francisco, CA, USA)

    Objective: The aims of this study are 1) to study the neurophysiology underlying anxiety and depression in PD patients, and 2) to determine whether cortical…
  • 2018 International Congress

    PrP as a receptor of alpha-synuclein in the pancreas of patients with synucleinopathies

    I. Martinez-Valbuena (Pamplona, Spain)

    Objective: We have investigated whether the cellular prion protein interacts with alpha-synuclein in pancreatic cells of patients with synucleinopathies. Background: Neurodegenerative diseases such as Alzheimer’s…
  • 2018 International Congress

    Vascular risk factors prevalence differences between Vascular Parkinsonism (VaP) and Parkinson Disease (PD) in a hospital cross-section study

    A. Velon, M. Mendes, R. Raimundo, R. Jesus, R. Almendra (Vila Real, Portugal)

    Objective: Determine and compare vascular risk factors between VaP and PD patients in a hospital-based sample. Background: Most studies demonstrate that vascular risk factors are…
  • 2018 International Congress

    Effects of Glial Heme Oxygenase-1 on Neuronal Alpha-Synuclein in the GFAP.HMOX1 Mouse Model of Parkinson’s Disease

    M. Cressatti, W. Song, A. Turk, C. Galindez, H. Schipper (Montreal, QC, Canada)

    Objective: To determine whether astroglial HO-1 transduces environmental and endogenous stressors into patterns of neural damage which promote the toxicity of neuronal alpha-synuclein. Background: The…
  • 2018 International Congress

    Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Cerebrospinal Fluid C-Reactive Protein

    H. Sanjari Moghaddam, M.H. Aarabi (Tehran, Islamic Republic of Iran)

    Objective: In this study, we intended to investigate the association between severity of PD motor symptoms and the cerebrospinal fluid (CSF) levels of CRP using…
  • 2018 International Congress

    A patient with myotonic dystrophy type 1 and parkinsonism

    J. Choi, J. Lee, H. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: We report the first case of myotonic dystrophy (DM) type 1 with DMPK mutations presenting with parkinsonian syndrome. Background: DM type 1 is a…
  • 2018 International Congress

    Enhancing protein palmitoylation is protective in alpha-synuclein dependent cytotoxicity

    G. Ho, T. Imberdis, S. Nuber, U. Dettmer, D. Selkoe (Boston, MA, USA)

    Objective: To determine if enhancement of protein palmitoylation benefits alpha-synuclein (aS) dependent vesicular trafficking defects and cytotoxicity. Background: Recent studies suggest that vesicular trafficking defects…
  • « Previous Page
  • 1
  • …
  • 1569
  • 1570
  • 1571
  • 1572
  • 1573
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley